3 ASX lithium shares just upgraded by Citi

Citi says Core Lithium and two other ASX lithium stocks deserve ratings upgrades.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX lithium shares have experienced volatile trading this year due to large fluctuations in lithium commodity prices and the macroeconomics at play in China.

As reported in The Australian, top broker Citi has just upgraded the following three ASX lithium shares.

Let's take a look.

Three satisfied miners with their arms crossed looking at the camera proudly

Image source: Getty Images

Citi re-rates 3 ASX lithium shares

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is up 1.89% to 38 cents at the time of writing on Thursday. Citi has raised its rating on the ASX lithium share to neutral with a 12-month price target of 38 cents.

IGO Ltd (ASX: IGO)

The IGO share price is 0.13% lower at $11.45. Citi has raised its rating on the ASX lithium share to buy and has cut its 12-month price target by 16% to $13.

Pilbara Minerals Ltd (ASX: PLS)

The Pilbara Minerals share price is 0.99% higher at $4.08. Citi has raised its rating on the ASX lithium share to buy with a 12-month price target of $4.50.

What's next for lithium prices?

The chart below shows the recent history of lithium futures and the share prices of these three ASX lithium shares above. Not surprisingly, the trajectory of the share price movements somewhat mimics the commodity. This is because commodity prices directly affect revenues (and dividends).

Citi thinks lithium prices could fall another 15% to 20% before a strong long-term rebound.

The broker's short-term forecast is for the lithium carbonate price to fall to US$18,000 and the CME hydroxide price to fall to $22,000 per tonne over the next year. Its long-term forecast for lithium carbonate is US$20,000 per tonne, and for lithium hydroxide, it's US$23,000 per tonne.

The current subdued Chinese economy has direct implications for Australian lithium exports, given it is our biggest customer. About 98% of the spodumene we dug up in 2022-23 was exported to China.

Analysis from Trading Economics discusses the current situation in China, as it pertains to lithium prices:

The concerning macroeconomic backdrop for the Chinese economy also translated to low consumer spending for electric automobiles, driving 10 Chinese new-energy vehicle producers to offer price cuts to reduce the supply glut.

Consequently, lower input demand resulted in a 10% reduction in battery prices in August, according to key market players.

Additionally, further demand concerns emerged after the EU launched an investigation on predatory pricing for Chinese vehicles due to Beijing's subsidies, risking tariffs and trade barriers.

Australia represents 50% of global lithium extraction, and we did a record $20 billion in lithium exports in 2022-23. The federal resources department expects our revenue to decrease in 2024-25 to $16 billion, despite an anticipated lift in export volumes due to lower lithium prices caused by surplus supply.

In the department's latest quarterly report and outlook, it said:

Australian lithium mine production continues growing due to expansions and new mines. Australia accounts for half of global lithium extraction and rising production meets growing global battery demand for lithium.

Australia also has an emerging lithium refining industry. So, instead of shipping our spodumene and carbonate off to other countries to be refined into lithium hydroxide, we'll do the refining ourselves.

Hydroxide is the preferred chemical form of lithium used in electric vehicle (EV) batteries. Global consultancy McKinsey says downstream processing could be worth an extra US$10 billion to the Australian economy. McKinsey says demand for hydroxide will overtake carbonate from 2026.

The department's report notes:

Australia is developing capacity to refine lithium domestically, with three lithium hydroxide refineries (operating or under construction) and a newly announced lithium phosphate refinery. This contributes to the diversifying global lithium refining and developing Australia's battery value chain.

To learn which ASX lithium share listed above already has a lithium hydroxide plant in operation, click here.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bronwyn Allen has positions in Core Lithium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »